bioMérieux offers the multiplex PCR-based BIOFIRE SPOTFIRE Respiratory Panel Mini. The new panel is designed to deliver speed and accuracy, detecting five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, Influenza A and B, Respiratory Syncytial Virus (RSV), and Rhinovirus, in approximately 15 minutes. The system is a small, scalable, multiplex PCR platform designed to bring central laboratory diagnostic results to the decentralized point-of-care (POC) clinical setting. It is capable of running a large multiplex respiratory test in the 12-25 pathogen target range, and a small multiplex respiratory test in the 3-5 pathogen target range. With a US FDA CLIA-waiver, the BIOFIRE SPOTFIRE System and its two existing respiratory panels may be used by non-lab professionals at the point of care.